Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(1H-1,2,3-triazol-5-yl)pyridine | Co(II)-form, Ki,app-value 41 nM | Homo sapiens | |
2-methyl-6-(1H-1,2,3-triazol-5-yl)pyridine | Co(II)-form, Ki,app-value 6 nM | Homo sapiens | |
3,8-dihydroindeno(1,2-d)(1,2,3)triazole | Co(II)-form, Ki,app-value 52 nM | Homo sapiens | |
3-(1H-1,2,3-triazol-5-yl)aniline | Co(II)-form, Ki,app-value 280 nM | Homo sapiens | |
3-(1H-1,2,3-triazol-5-yl)phenol | Co(II)-form, Ki,app-value 300 nM | Homo sapiens | |
3-(1H-1,2,3-triazol-5-yl)pyridine | Co(II)-form, Ki,app-value 260 nM | Homo sapiens | |
3-methyl-2-(1H-1,2,3-triazol-5-yl)pyridine | Co(II)-form, Ki,app-value 52 nM | Homo sapiens | |
4-(1H-1,2,3-triazol-5-yl)aniline | Co(II)-form, Ki,app-value 337 nM | Homo sapiens | |
4-(1H-1,2,3-triazol-5-yl)phenol | Co(II)-form, Ki,app-value above 1000 nM | Homo sapiens | |
4-(1H-1,2,3-triazol-5-yl)pyridine | Co(II)-form, Ki,app-value above 1000 nM | Homo sapiens | |
4-methyl-2-(1H-1,2,3-triazol-5-yl)pyridine | Co(II)-form, Ki,app-value 8 nM, Mn(II)-form, 0.014 mM, 50% reduction of viability of human umbilical vein endothelial cell above 0.03 mM | Homo sapiens | |
5-(1-benzofuran-2-yl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 15 nM, Mn(II)-form, 26% inhibition at 0.02 mM, 50% reduction of viability of human umbilical vein endothelial cell at 0.006 mM | Homo sapiens | |
5-(2-methoxyphenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 150 nM | Homo sapiens | |
5-(2-methylphenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 112 nM | Homo sapiens | |
5-(3,4-dibromophenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 1 nM, Mn(II)-form, 0.016 mM, 50% reduction of viability of human umbilical vein endothelial cell at 0.002 mM | Homo sapiens | |
5-(3-bromophenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 4 nM | Homo sapiens | |
5-(3-iodophenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 16 nM | Homo sapiens | |
5-(3-methylphenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 18 nM | Homo sapiens | |
5-(4-bromophenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 3 nM, Mn(II)-form, 0.011 mM, 50% reduction of viability of human umbilical vein endothelial cell at 0.006 mM | Homo sapiens | |
5-(4-chlorophenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 6 nM, Mn(II)-form, 0.011 mM, 50% reduction of viability of human umbilical vein endothelial cell at 0.005 mM | Homo sapiens | |
5-(4-ethylphenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 30 nM | Homo sapiens | |
5-(4-iodophenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 1 nM, Mn(II)-form, not inhibitory at 0.02 mM, 50% reduction of viability of human umbilical vein endothelial cell at 0.02 mM | Homo sapiens | |
5-(4-methylphenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 15 nM, Mn(II)-form, 4400 nM, 50% reduction of viability of human umbilical vein endothelial cell at 0.03 mM | Homo sapiens | |
5-(4-propylphenyl)-1H-1,2,3-triazole | Co(II)-form, Ki,app-value above 1000 nM | Homo sapiens | |
5-biphenyl-2-yl-1H-1,2,3-triazole | Co(II)-form, Ki,app-value above 1000 nM | Homo sapiens | |
5-methyl-2-(1H-1,2,3-triazol-5-yl)pyridine | Co(II)-form, Ki,app-value 3 nM, Mn(II)-form, 0.015 mM, 50% reduction of viability of human umbilical vein endothelial cell at 0.002 mM | Homo sapiens | |
5-phenyl-1H-1,2,3-triazole | Co(II)-form, Ki,app-value 70 nM | Homo sapiens | |
N-benzyl-3-(1H-1,2,3-triazol-5-yl)aniline | Co(II)-form, Ki,app-value 29 nM | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
isoform ยตetAP2 | - |